some work in inflammatory bowel disease (PMID: 22300085) A clinical trial has been registered, though its current status is unclear (PMID: 40756949) Regulatory note: BPC-157 is prohibited by WADA/USADA for sport use (added to the Prohibited List in 2022)
Little pharmacokinetic data is available on other components of gila monster venom, including helodermin, hyaluronidase, amine oxidase, and phospholipase A
Rare but severe side effects include digestive, kidney, and thyroid issues, hair loss, rapid heart rate, vision problems, and mental health concerns
We will make these insights clinically actionable via noninvasive DNA tests supported by our results reporting platform and CLIA lab partners, said Steve Gardner, Chief Executive Officer of PrecisionLife